ROIV Roivant Sciences Ltd.: institutional ownership and insider trading
542 funds reported holding $21.5B of Roivant Sciences Ltd. in their latest 13F filings; in Q2 2026 funds net bought $1.58B, with 96 new positions and 42 funds selling out; over the last 12 months insiders bought $0 and sold $885M on the open market.
Famous investors holding ROIV
- David Einhorn (Greenlight Capital): $76.2M, 2.0% of the portfolio
- Lee Ainslie (Maverick Capital): $100M, 0.9% of the portfolio
- Andreas Halvorsen (Viking Global Investors): $222M, 0.6% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $105M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $206M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $24.8M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $779K, 0.0% of the portfolio
Largest institutional holders of ROIV
- FMR LLC — $2.87B
- BlackRock, Inc. (BLK) — $1.71B
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $1.51B
- VANGUARD GROUP INC — $913M
- QVT Financial LP — $840M
- VANGUARD CAPITAL MANAGEMENT LLC — $783M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $766M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $657M
- STATE STREET CORP (STT, STT-PG) — $630M
- UBS Group AG (UBS) — $618M
Recent ROIV insider trades
- Oct 20, 2026: Venker Eric sold 200,000 shares ($7.02M)
- Oct 1, 2026: Epperly Melissa B, sold 17,750 shares ($641K)
- Sep 30, 2026: Venker Eric sold 200,000 shares ($7.32M)
- Sep 15, 2026: Fitzgerald Meghan sold 5,112 shares ($203K)
Members of Congress trading ROIV
- Oct 31, 2025: Lisa C. McClain sold $1.00K–$15.0K
- Oct 30, 2025: Lisa C. McClain bought $1.00K–$15.0K
- Oct 30, 2025: Lisa C. McClain sold $1.00K–$15.0K
- Jun 17, 2025: Lisa C. McClain bought $1.00K–$15.0K
5%+ owners
- Morgan Stanley: 5.7% (Schedule 13G/A, filed Aug 13, 2026)